These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 17254929

  • 21. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience.
    Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, Schwartz ME.
    Am J Surg; 2008 Aug; 196(2):160-9. PubMed ID: 18466862
    [Abstract] [Full Text] [Related]

  • 22. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
    Yedibela S, Demir R, Zhang W, Meyer T, Hohenberger W, Schönleben F.
    Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
    [Abstract] [Full Text] [Related]

  • 23. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.
    Neuhaus P, Thelen A, Jonas S, Puhl G, Denecke T, Veltzke-Schlieker W, Seehofer D.
    Ann Surg Oncol; 2012 May; 19(5):1602-8. PubMed ID: 21964888
    [Abstract] [Full Text] [Related]

  • 24. [Clinical analysis of curative resection with hemihepatectomy for advanced hilar cholangiocarcinoma].
    Sun Y, Wu ZY, Hao CY, Huang XF, Wang K, Bao Q, Qian HG, Xing BC.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 26; 88(8):527-30. PubMed ID: 18649767
    [Abstract] [Full Text] [Related]

  • 25. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
    Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H.
    J Surg Oncol; 2007 Aug 01; 96(2):160-5. PubMed ID: 17443744
    [Abstract] [Full Text] [Related]

  • 26. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
    Yamashita Y, Taketomi A, Morita K, Fukuhara T, Ueda S, Sanefuji K, Iguchi T, Kayashima H, Sugimachi K, Maehara Y.
    Anticancer Res; 2008 Aug 01; 28(4C):2353-9. PubMed ID: 18751418
    [Abstract] [Full Text] [Related]

  • 27. Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy.
    Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Miyazaki M.
    Ann Surg; 2010 Feb 01; 251(2):281-6. PubMed ID: 20054275
    [Abstract] [Full Text] [Related]

  • 28. Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma.
    Jiang BG, Sun LL, Yu WL, Tang ZH, Zong M, Zhang YJ.
    Cancer J; 2009 Feb 01; 15(3):257-61. PubMed ID: 19556914
    [Abstract] [Full Text] [Related]

  • 29. Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases.
    Ikeyama T, Nagino M, Oda K, Ebata T, Nishio H, Nimura Y.
    Ann Surg; 2007 Dec 01; 246(6):1052-7. PubMed ID: 18043110
    [Abstract] [Full Text] [Related]

  • 30. Diagnostic and surgical features of Klatskin tumors.
    Santoro E, Sacchi M, Carboni F, Santoro R, Scardamaglia F.
    Chir Ital; 1999 Dec 01; 51(1):1-7. PubMed ID: 10514910
    [Abstract] [Full Text] [Related]

  • 31. Resection and drainage of hilar cholangiocarcinoma: an 11-year experience of a single center in mainland China.
    Zheng-Rong L, Hai-Bo Y, Xin C, Chuan-Xin W, Zuo-Jin L, Bing T, Jian-Ping G, Sheng-Wei L.
    Am Surg; 2011 May 01; 77(5):627-33. PubMed ID: 21679599
    [Abstract] [Full Text] [Related]

  • 32. Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors.
    Havlik R, Sbisà E, Tullo A, Kelly MD, Mitry RR, Jiao LR, Mansour MR, Honda K, Habib NA.
    Hepatogastroenterology; 2000 May 01; 47(34):927-31. PubMed ID: 11020850
    [Abstract] [Full Text] [Related]

  • 33. Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results.
    Seehofer D, Thelen A, Neumann UP, Veltzke-Schlieker W, Denecke T, Kamphues C, Pratschke J, Jonas S, Neuhaus P.
    Liver Transpl; 2009 Nov 01; 15(11):1499-507. PubMed ID: 19877250
    [Abstract] [Full Text] [Related]

  • 34. [Prognostic factors after surgical resection for hilar cholangiocarcinoma].
    Ramacciato G, Corigliano N, Mercantini P, Di Benedetto F, Masetti M, Ercolani G, Lauro A, De Ruvo N, Pinna AD.
    Ann Chir; 2006 Nov 01; 131(6-7):379-85. PubMed ID: 16806037
    [Abstract] [Full Text] [Related]

  • 35. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T, Shimada K, Sakamoto Y, Ojima H, Esaki M, Kosuge T.
    Ann Surg Oncol; 2008 Feb 01; 15(2):590-9. PubMed ID: 18057991
    [Abstract] [Full Text] [Related]

  • 36. Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma.
    Jan YY, Jeng LB, Hwang TL, Wang CS, Chen MF, Chen TJ.
    Hepatogastroenterology; 1996 Feb 01; 43(9):614-9. PubMed ID: 8799405
    [Abstract] [Full Text] [Related]

  • 37. Role of hilar resection in the treatment of hilar cholangiocarcinoma.
    Otani K, Chijiiwa K, Kai M, Ohuchida J, Nagano M, Kondo K.
    Hepatogastroenterology; 2012 May 01; 59(115):696-700. PubMed ID: 22469711
    [Abstract] [Full Text] [Related]

  • 38. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.
    Lee SG, Song GW, Hwang S, Ha TY, Moon DB, Jung DH, Kim KH, Ahn CS, Kim MH, Lee SK, Sung KB, Ko GY.
    J Hepatobiliary Pancreat Sci; 2010 Jul 01; 17(4):476-89. PubMed ID: 19851704
    [Abstract] [Full Text] [Related]

  • 39. Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma.
    Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, Shimamura F, Shimizu Y, Miyazaki M.
    J Hepatobiliary Pancreat Surg; 2003 Jul 01; 10(4):259-64. PubMed ID: 14598144
    [Abstract] [Full Text] [Related]

  • 40. Resectability and prognostic factors after resection of hilar cholangiocarcinoma.
    Abdel Wahab M, Fathy O, Elghwalby N, Sultan A, Elebidy E, Abdalla T, Elshobary M, Mostafa M, Foad A, Kandeel T, Abdel Raouf A, Salah T, Abu Zeid M, Abu Elenein A, Gad Elhak N, ElFiky A, Ezzat F.
    Hepatogastroenterology; 2006 Jul 01; 53(67):5-10. PubMed ID: 16506367
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.